skip to primary navigationskip to content
 

Cambridge BBSRC DTP Programme Students Proceed to Final of 2017 Biotechnology YES Competition

last modified Nov 06, 2017 10:11 AM

Cambridge BBSRC DTP Programme Students Proceed to Final of 2017 Biotechnology YES Competition

Congratulations to Aurora Diamante, Matthew Ratcliff, Thomas Sharrock, Callum Talbot-Cooper and Theodors Pantelejevs, one of three winning teams for the 2017 Biotechnology YES Competition.

Aurora Diamante said:

"Team members recently attended the three-day Biomedical Workshop in London as part of the competition. At the workshop, each team optimised a business plan around a plausible biomedical idea to be developed by an hypothetical company. Our company, called SynapteX, is developing the first non-hormonal, reversible male contraceptive pill and, following successful pre-clinical trials in animals, is looking for venture capital investments in order to start the Phase I clinical trial in humans. On the last day of the competition, each team pitched in front of a panel of equity investors. Us, the other winning teams of the Biomedical Workshop and the selected teams from the other workshops will now progress to the final, hosted at the The Royal Society in London on Tuesday 12 December 2017.

Since most team members are supported by BBSRC, we would like to deeply thank the BBSRC for giving us the chance to take part in this competition." 

 

Aurora, Matthew, Thomas and Callum are 2016 cohort PhD students in the BBSRC DTP Programme. The Programme is interdisciplinary in nature, with students undertaking research in Pharmacology (Aurora), Biochemistry (Matthew), Physiology, Development and Neuroscience (Thomas) and Pathology (Callum), as well many other Departments and Partner Institutes

Congrats Aurora, Matthew, Thomas, Callum and Theodors!

Biotechnology YES 2017 Winners